dose-response inhibition module in graphpad prism version 5.0 software (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
dose-response inhibition module in graphpad prism version 5.0 software
Dose Response Inhibition Module In Graphpad Prism Version 5.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dose-response+inhibition+module+in+graphpad+prism+version+5%2E0+software/dose+response+inhibition+module+in+graphpad+prism+version+5+0+software/pm33592379-55-10-9
Average 90 stars, based on 1 article reviews
Dose Response Inhibition Module In Graphpad Prism Version 5.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dose-response+inhibition+module+in+graphpad+prism+version+5%2E0+software/dose+response+inhibition+module+in+graphpad+prism+version+5+0+software/pm33592379-55-10-9
Average 90 stars, based on 1 article reviews
dose-response inhibition module in graphpad prism version 5.0 software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Inhibition:Article Title: Coibamide A kills cancer cells through inhibiting autophagy. Article Snippet: Natural products are useful tools for biological mechanism research and drug discovery.. Due to the excellent tumor cell growth inhibitory profile and sub-nanomolar potency, Coibamide A (CA), an Nmethyl-stabilized depsipeptide isolated from marine cyanobacterium, has been considered as a promising lead compound for cancer treatment.. However, the molecular anti-cancer mechanism of the action of CA remains unclear. Software:Article Title: Coibamide A kills cancer cells through inhibiting autophagy. Article Snippet: Natural products are useful tools for biological mechanism research and drug discovery.. Due to the excellent tumor cell growth inhibitory profile and sub-nanomolar potency, Coibamide A (CA), an Nmethyl-stabilized depsipeptide isolated from marine cyanobacterium, has been considered as a promising lead compound for cancer treatment.. However, the molecular anti-cancer mechanism of the action of CA remains unclear. |